Triglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patients

Zhengwen Xu1, Xisheng Yan1, Dongsheng Li2

  • 1Department of Cardiology, Wuhan Third Hospital & Tongren Hospital of Wuhan University, Wuhan, 430074, Hubei, China.

Scientific Reports
|February 9, 2025
PubMed

Insights

The Triglyceride-Glucose (TyG) index, a marker for insulin resistance, significantly predicts heart failure (HF) risk in patients with H-type hypertension. Higher TyG index values indicate a greater likelihood of developing HF, especially in diabetic individuals.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Syndrome
  • Hypertension Research

Background:

  • Heart failure (HF) is a major global health concern, particularly prevalent in individuals with H-type hypertension, characterized by high blood pressure and elevated homocysteine.
  • The Triglyceride-Glucose (TyG) index, a validated surrogate marker for insulin resistance, has emerged as a potential predictor of cardiovascular events, but its specific role in HF development within the H-type hypertension population requires further investigation.

Purpose of the Study:

  • To investigate the association between the Triglyceride-Glucose (TyG) index and the incidence of heart failure (HF) in patients diagnosed with H-type hypertension.
  • To evaluate the predictive performance of the TyG index for HF risk stratification in this specific patient cohort.

Main Methods:

  • A retrospective cohort study involving 1200 patients with H-type hypertension was conducted.
  • The Triglyceride-Glucose (TyG) index was calculated using fasting triglyceride and glucose levels.
  • Multivariate Cox regression analysis, adjusted for key demographic and lifestyle factors, was employed to assess the impact of the TyG index on HF incidence.

Main Results:

  • A total of 254 patients (21.2%) developed heart failure during a median follow-up of 24 months.
  • Elevated Triglyceride-Glucose (TyG) index values were significantly correlated with an increased risk of heart failure (HR 1.45 per unit increase, p < 0.001).
  • The association between higher TyG index and HF risk was more pronounced in patients with diabetes mellitus. The TyG index demonstrated good predictive accuracy (AUC = 0.78) with a cut-off of 8.88.

Conclusions:

  • The Triglyceride-Glucose (TyG) index serves as a significant independent predictor of heart failure incidence in patients with H-type hypertension.
  • The TyG index offers a cost-effective tool for early risk stratification of heart failure in high-risk populations, particularly those with diabetes.
  • Routine integration of TyG index assessment into clinical practice may enhance the management and improve outcomes for patients with H-type hypertension.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
43
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
118
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
86